RecruitingNot ApplicableNCT06909357

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients Throughout Florida


Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Enrollment

90 participants

Start Date

Mar 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Despite the deleterious impact of smoking upon cancer treatment outcomes, smoking prevalence remains alarmingly high among cancer patients. Thus, reducing smoking by cancer patients is a public health priority, but treatments to date have demonstrated limited efficacy. Mobile health (mHealth) interventions have the potential to improve treatment efficacy while also greatly extending reach. The goal of this infrastructure proposal is to build a resource to facilitate the creation of mHealth tools that address the tobacco treatment needs of cancer patients. This resource, which will be available to researchers throughout Florida, would fill a critical gap in mHealth capacity.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • ≥18 years of age.
  • ≥100 lifetime cigarettes.
  • English-speaking.
  • Report smoking ≥ 1 cigarette in past 30 days.
  • Working smartphone.

Exclusion Criteria2

  • Failure to electronically confirm participation within 14 days of randomization via electronic link sent to participant's smartphone.
  • Currently pregnant or breastfeeding.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuitline Treatment (QT)

Tobacco Free Florida Quitline. 10-week supply of Combination Nicotine Replacement Therapy (NRT).

OTHERApp-based Treatment (mHealth)

Fully automated digitally-delivered smoking cessation intervention targeted to cancer patients. 10-week supply of Combination Nicotine Replacement Therapy (NRT).


Locations(3)

University of Miami

Coral Gables, Florida, United States

University of Florida

Gainesville, Florida, United States

Moffitt Cancer Center

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06909357


Related Trials